This review uncovers therapeutic resistance driven by myeloid-derived suppressor cells in tumors, indicating potential targeting strategies.
Myeloid-derived suppressor cell (MDSC) is a population with immunosuppressive characteristics in the tumor microenvironment, which are linked to poor prognosis and therapeutic resistance across cancers. In this review, a novel concept of MDSC and a quantity-quality pattern are proposed to illustrate the spatiotemporal dynamics of MDSC fate. By reviewing current researches through this framework, a group of pro-tumor signals is identified to have critical roles in the whole life cycle of MDSC evolution, including IMC proliferation, differentiation education, suppressive functioning of MDSC, and targeting strategy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: